The Asian Harmonization Working Party (AHWP) has recently drafted a post-marketing system to harmonize medical device adverse event reporting. AHWP members have varied systems for adverse event reporting, and some have no system at all. The new draft document aims at reducing... Read More
The World Health Organization (WHO) and various international partners came together in Germany November 2006 to develop a task force focused on preventing the global spread of counterfeit medicines. The International Medical Products Anti-Counterfeiting Taskforce, or IMPACT would cover legal, technological, communications... Read More
The Asian Harmonization Working Party (AHWP) has recently drafted a “Common Submission Dossier Template” (CSDT). If adopted, this would allow medical device companies to use one common form when submitting to any of the 13 countries in the AHWP. By adopting this... Read More
On January 1, 2007, Vietnam will officially enter the World Trade Organization (WTO). Several new rules will apply to the country’s medical industry as a part of accession. The Drug Administration of Vietnam (DAV) has stated that from that date, all drug... Read More
Vietnam’s Ministry of Health (MOH) recently announced plans that will include increased purchases for the country’s national health system. On August 10, 2006, at a national conference, the MOH announced it would upgrade the communal medical stations in villages and city wards.... Read More
Vietnam ‘s new Pharmaceutical Law, approved by the Vietnamese National Assembly in May 2005, will go into effect October 1, 2005. The Pharmaceutical Law addresses the development of the domestic pharmaceutical industry and State control over drug pricing, in addition to other... Read More
As Vietnam’s economy continues to expand (7.7 percent GDP growth in 2004), the country’s middle class population is growing, and spending is on the rise. More and more women are willing to purchase affordable, and occasionally, higher-end cosmetics. Vietnam’s cosmetic industry is... Read More
Vietnam 's population totals around 84 million and its economy boasted a 7.7 percent GDP growth rate in 2004. While Vietnam's healthcare industry is still developing, it is one of the faster growing markets in the global healthcare industry. In 2003, Vietnam... Read More
To expand their sales in the Asian medical markets, medical companies need to stay abreast of the new and changing regulatory environments for drugs, devices and In Vitro Diagnostics (IVDs). New or improved regulations are implemented frequently in Asia, including changes in... Read More
Vietnam’s pharmaceutical market is opening up and foreign-invested enterprises are beginning to play a larger role in the country, now contributing over 60% of the total prescription drugs available in Vietnam. However, conducting business in Vietnam is difficult, especially in the pharmaceutical... Read More